Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
21
02
2019
accepted:
10
12
2019
entrez:
27
12
2019
pubmed:
27
12
2019
medline:
3
4
2020
Statut:
epublish
Résumé
Europe has been dealing with an increasing number of refugees during the past 5 years. The timing of screening and vaccination of refugees is debated by many professionals, however refugees' perspectives on health issues are infrequently taken into account. In this study, we aimed to investigate asylum seekers' perspectives on infectious diseases screening and vaccination policies. Interviews were conducted in Greece and the Netherlands. Asylum seekers and recently arrived refugees were approached and informed with the help of interpreters; consent forms were acquired. The survey focused on demographic data, vaccination status, screening policies and prevention of infectious diseases. A total of 61 (43 male, 70.5%) refugees (30 Afghanis, 16 Syrian, 7 Erithrean) were interviewed. Mean age was 35.2 years (SD 13.5) and 50% had received primary or secondary education, while 24.6% received none. Median time after arrival in Greece and the Netherlands was 24 months (IQR 8.5-28). 44 out of 61 (72.1) participants were willing to be vaccinated after arrival in Europe, 26 preferred vaccination and screening to be performed at the point of entry. The need for screening and vaccination was perceived higher amongst participants in Greece (100% vs 43.3%) due to living conditions leading to increased risk of outbreaks. Participants were willing to communicate their perspectives and concerns. Screening and vaccination programs could be more effective when implemented shortly after arrival and by involving asylum seekers and refugees when developing screening and vaccination interventions.
Identifiants
pubmed: 31877563
doi: 10.1371/journal.pone.0226948
pii: PONE-D-19-05249
pmc: PMC6932865
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0226948Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet Infect Dis. 2014 Dec;14(12):1171-2
pubmed: 25455973
BMC Res Notes. 2017 Jun 19;10(1):216
pubmed: 28629409
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 May;59(5):592-8
pubmed: 27072499
Euro Surveill. 2018 Oct;23(41):
pubmed: 30326996
BMC Med Ethics. 2018 Mar 2;19(1):16
pubmed: 29499693
Euro Surveill. 2015 Jul 30;20(30):null
pubmed: 26250069
Internist (Berl). 2016 May;57(5):416-33
pubmed: 27138489
PLoS One. 2017 Apr 25;12(4):e0176481
pubmed: 28441421
J Travel Med. 2018 Jan 1;25(1):null
pubmed: 29232456
Vaccine. 2018 Mar 14;36(12):1664-1672
pubmed: 29454516
Lancet Infect Dis. 2018 Jul;18(7):796-811
pubmed: 29779917
Thorax. 2010 Aug;65(8):663-5
pubmed: 20610450
PLoS Negl Trop Dis. 2018 May 17;12(5):e0006401
pubmed: 29771941
Vaccine. 2018 Feb 1;36(6):899-905
pubmed: 29306505
BMC Health Serv Res. 2016 Jan 15;16:14
pubmed: 26772613
Int J Environ Res Public Health. 2014 Oct 21;11(10):11004-14
pubmed: 25337945
Int J Behav Med. 2017 Dec;24(6):836-845
pubmed: 28620774
Lancet Glob Health. 2017 Mar;5(3):e252-e253
pubmed: 28193385